Leila Alland - Jul 7, 2021 Form 4 Insider Report for PMV Pharmaceuticals, Inc. (PMVP)

Signature
/s/ Winston Kung, by power of attorney
Stock symbol
PMVP
Transactions as of
Jul 7, 2021
Transactions value $
-$113,613
Form type
4
Date filed
7/8/2021, 04:10 PM
Previous filing
May 27, 2021
Next filing
Aug 10, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PMVP Common Stock Options Exercise $15.6K +4K $3.90 4K Jul 7, 2021 Direct
transaction PMVP Common Stock Sale -$62.3K -1.95K -48.78% $31.93 2.05K Jul 7, 2021 Direct F1, F2
transaction PMVP Common Stock Sale -$66.9K -2.05K -100% $32.66 0 Jul 7, 2021 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PMVP Employee Stock Option (right to buy) Options Exercise $0 -4K -1.09% $0.00 362K Jul 7, 2021 Common Stock 4K $3.90 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 30, 2020.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.455 to $32.40, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.455 to $32.835, inclusive.
F4 One-fourth of the shares subject to the option vested on December 3, 2020, and one forty-eighth of the shares subject to the option shall vest each month thereafter.